Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEpizyme, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/09/2022 | Q2 2022 | -$0.36 | -$0.25 | 0.11 | N/A | $27.53 M |
| 05/10/2022 | Q1 2022 | -$0.35 | -$0.38 | -0.03 | N/A | $8.70 M |
| 03/01/2022 | Q4 2021 | N/A | -$0.49 | N/A | N/A | $11.58 M |
| 11/09/2021 | Q3 2021 | -$0.48 | -$0.64 | -0.16 | N/A | $5.20 M |
| 08/09/2021 | Q2 2021 | -$0.62 | -$0.63 | -0.01 | N/A | $13.01 M |
| 05/06/2021 | Q1 2021 | -$0.57 | -$0.69 | -0.12 | N/A | $7.63 M |
| 02/23/2021 | Q4 2020 | -$0.58 | -$0.65 | -0.07 | N/A | $8.38 M |
| 11/06/2020 | Q3 2020 | -$0.60 | -$0.55 | 0.05 | N/A | $3.57 M |
| 08/04/2020 | Q2 2020 | -$0.61 | -$0.58 | 0.03 | N/A | $2.47 M |
| 05/04/2020 | Q1 2020 | -$0.74 | -$0.51 | 0.23 | N/A | $1.35 M |
| 02/27/2020 | Q4 2019 | N/A | -$0.59 | N/A | N/A | $4.29 M |
| 10/31/2019 | Q3 2019 | N/A | -$0.40 | N/A | N/A | $5.72 M |
| 08/09/2019 | Q2 2019 | -$0.53 | -$0.53 | 0 | N/A | $5.90 M |
| 05/06/2019 | Q1 2019 | -$0.46 | -$0.36 | 0.1 | N/A | $7.89 M |
| 02/26/2019 | Q4 2018 | -$0.47 | -$0.29 | 0.18 | N/A | $9.70 M |
| 11/02/2018 | Q3 2018 | -$0.61 | -$0.54 | 0.07 | N/A | $0 |
| 08/02/2018 | Q2 2018 | -$0.51 | -$0.42 | 0.09 | N/A | $12.00 M |
| 05/08/2018 | Q1 2018 | -$0.55 | -$0.49 | 0.06 | N/A | $0 |
| 03/13/2018 | Q4 2017 | -$0.57 | -$0.60 | -0.03 | N/A | $0 |
| 11/01/2017 | Q3 2017 | -$0.64 | -$0.63 | 0.01 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Epizyme, Inc. Earnings: FAQ's
In the previous quarter, Epizyme, Inc. (:EPZM) reported $-0.21 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.36 by $0.15.
The conference call for Epizyme, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Epizyme, Inc.'s latest earnings report can be read online.
Epizyme, Inc. (:EPZM) has a recorded annual revenue of $37.43 M.
Epizyme, Inc. (:EPZM) has a recorded net income of $-251,122,000.Epizyme, Inc. has generated $-2.49 earnings per share over the last four quarters.
Epizyme, Inc. (:EPZM) has a price-to-earnings ratio of -0.59 and price/earnings-to-growth ratio is -0.01.